Kuo M S, Yurek D A, Coats J H, Chung S T, Li G P
Chemical and Biological Screening, Upjohn Company, Kalamazoo, MI 49001.
J Antibiot (Tokyo). 1992 Nov;45(11):1773-7. doi: 10.7164/antibiotics.45.1773.
An accumulated lincomycin intermediate in UC 8292, a lincomycin nonproducing strain of Streptomyces lincolnensis, has been isolated and purified by employing an assay system based on complementation of UC 11066, another lincomycin nonproducing strain of S. lincolnensis. The structure of the purified intermediate is shown to be 3-propylidene-delta 1-pyrroline-5-carboxylic acid, or 1, 2, 3, 6-tetradehydro-propylproline by mass spectrometry and NMR spectroscopic studies. Based on the structure of this newly found intermediate, a biosynthetic pathway for propylproline is proposed as tyrosine-->L-3-hydroxytyrosine (Dopa)-->-->-->-->3-propylidene-delta 1-pyrroline-5-carboxylic acid-->3-propyl-delta 2-pyrroline-5-carboxylic acid-->propylproline.
林肯链霉菌的一个不产林可霉素的菌株UC 8292中积累的一种林可霉素中间体,已通过基于林肯链霉菌的另一个不产林可霉素的菌株UC 11066互补作用的检测系统进行了分离和纯化。通过质谱和核磁共振光谱研究表明,纯化中间体的结构为3-亚丙基-δ1-吡咯啉-5-羧酸,或1,2,3,6-四脱氢丙基脯氨酸。基于这种新发现中间体的结构,提出了丙基脯氨酸的生物合成途径为酪氨酸→L-3-羟基酪氨酸(多巴)→→→→3-亚丙基-δ1-吡咯啉-5-羧酸→3-丙基-δ2-吡咯啉-5-羧酸→丙基脯氨酸。